Live Quote · NASDAQINMBHealthcare· Biotechnology

INmune Bio, Inc.

$0.83▼ 7.50%($-0.07)
MKT CAP $25.60MNEXT EARNINGS Mar 4, 2027
50%
Bullish
TickerSpark Score
63/100
▌ Mixed
90
Valuation
20
Profitability
90
Growth
84
Health
30
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a INMB research report →

Analyst Price Target
$22.00+2560.2% vs. today

Range $22 – $22

Analyst RatingBuy
6 Buy2 Hold1 Sell

Price Chart

-40.79% · this period
$2.51$1.70$0.89Nov 19May 22Nov 19
52-Week Range0% of range
Low
$0.82
Current
$0.83
High
$2.60